129 related articles for article (PubMed ID: 3239479)
21. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
22. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
23. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study on the clinical effects and endometrial findings of IUD].
Chao CK
Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
[TBL] [Abstract][Full Text] [Related]
25. [Endometrial estrogen and progesterone receptors in women wearing intrauterine contraceptive devices].
Niu EM
Zhonghua Fu Chan Ke Za Zhi; 1985 May; 20(3):160-3, 190. PubMed ID: 4017739
[No Abstract] [Full Text] [Related]
26. The effect of copper in vivo on specific progesterone binding by human endometrial cytosol.
Bonaventura LM; Cleary RE; Young PC
Fertil Steril; 1979 Nov; 32(5):531-5. PubMed ID: 499584
[TBL] [Abstract][Full Text] [Related]
27. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
28. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
29. Corrosion of filamentous intra-uterine copper. The MLCu250 and the MLCu375.
Kosonen A; Thiery M
Contraception; 1983 Jan; 27(1):85-93. PubMed ID: 6839762
[TBL] [Abstract][Full Text] [Related]
30. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
Andersson K; Odlind V; Rybo G
Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
[TBL] [Abstract][Full Text] [Related]
31. Comparative performance of two copper IUDs: Nova-T and MLCu375.
de Castro A; Anguiano JM
Adv Contracept; 1986 Jun; 2(2):155-9. PubMed ID: 3535433
[TBL] [Abstract][Full Text] [Related]
32. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
Umapathysivam K; Jones WR
Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
[TBL] [Abstract][Full Text] [Related]
33. Endometrial oestrogen and progesterone receptors and their relationship to sonographic appearance of the endometrium.
Ohno Y; Fujimoto Y
Hum Reprod Update; 1998; 4(5):560-4. PubMed ID: 10027609
[TBL] [Abstract][Full Text] [Related]
34. Medicated intrauterine devices: development considerations and clinical uses.
Chien YW
J Parenter Drug Assoc; 1980; 34(4):295-323. PubMed ID: 6902777
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of action of intrauterine devices.
Ortiz ME; Croxatto HB; Bardin CW
Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S42-51. PubMed ID: 8972502
[TBL] [Abstract][Full Text] [Related]
36. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ.
Gu Z; Zhu P; Luo H; Zhu X; Zhang G; Wu S
Contraception; 1995 Jul; 52(1):57-61. PubMed ID: 8521716
[TBL] [Abstract][Full Text] [Related]
37. Ovarian function during use of a levonorgestrel-releasing IUD.
Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
[TBL] [Abstract][Full Text] [Related]
38. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
[TBL] [Abstract][Full Text] [Related]
39. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
[TBL] [Abstract][Full Text] [Related]
40. Endometrial estrogen and progestin receptors in women bearing a progesterone-releasing intrauterine device.
Jänne O; Ylöstalo P
Contraception; 1980 Jul; 22(1):19-23. PubMed ID: 7418404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
